-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster III

Symposia: Cellular Immunotherapies: Early Phase and Investigational Therapies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Jingjing Feng, MD1*, Yongxian HU2*, Alex H. Chang, Ph.D3,4* and He Huang5,6,7,8*

1The First affiliated Hospital, School of Medicine, Hangzhou, China
2Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China
4Shanghai YaKe Biotechnology Ltd., Shanghai, China
5Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China
6Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
7Institute of Hematology, Zhejiang University, Hangzhou, China
8Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China

Edo Schaefer, MD1, Christine Vu, DO2*, Allyson Flower, MD3*, Janet Ayello, MS, MT4*, Yaya Chu, PhD5*, Carmella Van De Ven, MS3*, Elizabeth Mintzer, CRA3*, Lauren Harrison, MSN, RN6*, Erin Morris, RN, BSN3*, Yongping Wang, MD, PhD7*, Shalini Shenoy, MD, MBBS8, Dean Anthony Lee, MD, PhD9, Rolla ABU-Arja, MD10*, Bryon D. Johnson, PhD11*, Michael R Verneris, MD12, Christopher C Dvorak, MD13, Julia Chu, MD, MPH14*, Kenneth R. Cooke, MD15, Julie-An Talano, MD16, Nancy Bunin, MD17 and Mitchell S. Cairo, MD5,18,19,20

1Pediatrics, New York Medical College, Rye, NY
2Pediatrics, New York Medical College, Valhalla, NY
3New York Medical College, Valhalla, NY
4westchester medical center, Valhalla, NY
5Department of Pediatrics, New York Medical College, Valhalla, NY
6New York Medical College, Valhall, NY
7Children’s Hospital of Philadelphia, Philadelphia, PA
8Washington University Medical Center, Saint Louis, MO
9Center for Childhood Cancer, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH
10Nationwide Children’s Hospital, Columbus, OH
11Department of Medicine, Medical College of Wisconsin, Milwaukee
12Children's Hospital Colorado, University of Colorado At Denver, Aurora, CO
13University of California, San Francisco, Millbrae, CA
14UCSF Benioff Children's Hospitals, San Francisco, CA
15The Sidney Kimmel Comp. Cancer Center At Johns Hopkins, Baltimore, MD
16Medical College of WI, Milwaukee, WI
17Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
18Department of Medicine, New York Medical College, Valhalla, NY
19Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY
20Department of Pathology/Microbiology and Immunology, New York Medical College, Valhalla, NY

Chunrui Li1,2, Di Wang3*, Atsuhiko Hasegawa, DVM, PhD4*, Huining Liu, MD, PhD5*, Ning An6*, Yuhan Bao6*, Meijuan Huang, MD7*, Yi Xiao, MD, PhD8*, Donghua Zhang2*, Miao Zheng, MD, PhD9*, Wei Huang, MD, PhD9* and Lijun Jiang, MD, PhD9*

1Institute of Hematolog;Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, CHN
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Institute of Hematolog; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4Tumor Cell Biology, Clinical Research Institute, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
5KOUSAI Bio Co.,Ltd, Shanghai, China
6Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wu Han, China
7Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, AL, China
8Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan, China
9Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong Un, Wuhan, China

Hasmukh Jain, MD, DM1*, Atharva Karulkar2*, Devanshi Kalra2*, Smrithi Ravikumar2*, Netra Ghandade2*, Ruchira Patil2*, Shreshtha Shah2*, Afrin Firfiray2*, Juber Pendhari3*, Rushikesh Patil, PhD2*, Manivasagam S2*, Neha Sharma4*, Alok Shetty, MD, DM5*, Lingaraj Nayak, MBBS, MD, DM5*, Bhausaheb Bagal, MD, DM5*, Shripad Banavali, MD5*, Gaurav Narula, MD1*, Preeti Desai, MD6*, Anisha Navkudkar, MD6*, Prashant Tembhare, MD, DM7*, Navin Khattry, MD, DM5*, Epari Sridhar, MD8*, Nikhil Patkar, MD7*, Sumeet Gujral, MD8*, Tanuja Shet, MBBS, MD, DPB, DNB, DTM8*, Uma Sakhadeo, MD8*, Papagudi Ganesan Subramanian, MD7*, Jayshree Thorat, MD2*, Anamika Prashant, MBBS5*, Sachin Punatar, MD, DM5*, Anant Gokarn, MD, DM5*, Kinjalka Ghosh, MD9*, Archi Agrawal10*, Yash Jain, MD10*, Venkatesh Rangarajan, MD10*, Shashank Ojha, MD6*, Shilpushp Bhosle, MD11*, Siddhartha Laskar, MD10*, Sangeeta Kakoti, MD10*, Sumeet Mirgh, MD, DM, MBBS5*, Sumathi Hiregoudar, MD12*, Minal Poojary, MBBS6*, Nitin Shetty, MD13*, Vasundhara Patil, MD13*, Akshay Baheti, MD13*, Sanjay Biswas, MD14*, Gaurav Salunkhe, MD14*, Kunal Gala, MD13*, Manju Sengar, MD, DM1, Nirali N. Shah, M.D.15, Sattva S. Neelapu, MD16 and Rahul Purwar, PhD2*

1Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
2Immunoadoptive Cell Therapy Private Limited, Mumbai, India
3Department of Biosciences and Bioengineering, Indian Institute of Technology, Bombay, Mumbai, India
4Department of Surgical Oncology, Tata Memorial Centre, Mumbai, India
5Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
6Department of Transfusion Medicine, Tata Memorial Centre, Mumbai, India
7Department of Hemato Pathology, Tata Memorial Centre, Mumbai, India
8Department of Pathology, Tata Memorial Centre, Mumbai, India
9Department of Biochemistry, Tata Memorial Centre, Mumbai, India
10Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India
11Department of Critical Care and Anaesthesiology, Tata Memorial Centre, Mumbai, India
12Department of Transfusion Medicine, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Mumbai, India
13Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, India
14Department of Microbiology, Tata Memorial Centre, Mumbai, India
15Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD
16Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Hrishikesh Srinagesh, MD, MSCR1*, John H. Baird, MD2, Neha Agarwal, MS1*, Yi-Jiun Su, MD1*, Anne Marijn Kramer, MD, PhD3*, Agnes Reschke, MD1*, Nikeshan Jeyakumar, MD1*, Sushma Bharadwaj, MD, MS1, Liora Michal Schultz, MD4, Sneha Ramakrishna5*, Kara L. Davis, DO6, Bita Sahaf, PhD, MSc7*, Steven Feldman, PhD3*, Crystal L. Mackall, MD8, David B. Miklos, MD, PhD9, Lori S. Muffly, MD1 and Matthew J. Frank, MD, PhD9

1Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
2Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
3Center for Cancer Cell Therapy, Stanford University, Stanford, CA
4Stanford University School of Medicine, Department of Pediatrics, Division of Hematology and Oncology, Palo Alto, CA
5Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA
6Department of Pediatrics, Hematology, Oncology, and Stem Cell Transplant and Regenerative Medicine, Stanford University, Stanford, CA
7Cancer Correlative Science Unit, Stanford University, Palo Alto, CA
8Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA
9Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA

John H. Baird, MD1, Marissa Morales Del Real, PhD2*, Joo Y. Song, MD3, Geoffrey P. Shouse, PhD, DO4, Alexey Danilov, MD5, Alex F. Herrera, MD6, Leslie L. Popplewell, MD, FACP, MPH1, Steven T. Rosen, MD7, Jennifer Davis, BSN RN8*, Baishakhi Barva, MBBS8*, Lu Chen, PhD9*, Larry W. Kwak, MD, PhD1, Stephen J. Forman, MD, FACP1 and Elizabeth Lihua Elizabeth Budde, MD, PhD10

1Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
2T-Cell Therapeutics Research Laboratories, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
3Beckman Research Institute, City of Hope, Duarte, CA
4Hematology/HCT, City of Hope National Medical Center, Duarte, CA
5Department of Hematology and HCT, City of Hope National Medical Center, La Canada Flintridge, CA
6City of Hope, Duarte, CA
7Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
8City of Hope National Medical Center, Duarte, CA
9Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
10Department of Hematology and HCT, City of Hope, Duarte, CA

Langqi Wang, MD1*, Jilong Yang, MD1*, Bo Jin, MD & PhD1*, Bo Wang, MD1*, Lijuan Zhou, MD1*, Yaqi Zhuo, MD1*, Huifang Chen, MD1*, Lung-Ji Chang, PhD2,3, Sanfang Tu1* and Yuhua Li1*

1Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
2School of Medicine, University of Electronic Science and Technology of China, Chengdu, Chengdu, China
3Geno-Immue Medical Institute, Shenzhen, China

Joseph E. Maakaron, MD1, Cassie Seichter1*, Rose Wangen2*, Andrea Hoeschen1*, Deepa Kolaseri Krishnadas2*, Kateryna Kent1*, Ryan Shanley3*, Daniel O'Leary, MD4, Najla El Jurdi, MD5, Shernan G. Holtan, MD6, Brian Betts, MD4, Mark Juckett, MD4 and Jeffrey S Miller, MD7

1Masonic Cancer Center, University of Minnesota, Minneapolis, MN
2University of Minnesota, Minneapolis, MN
3Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
4Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
5Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, minneapolis, MN
6Department of Medicine, Umn Medical School, Minneapolis, MN
7Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN

Yulan Zhou1*, Yulong Jin1*, Dexiang Ji, MD2*, Fancong Kong1*, Yu Peng3*, Min Yu1*, Shixuan Wang1*, Xiaoye Cheng1* and Fei Li, MD2

1Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
2The First Affiliated Hospital of Nanchang University, Nanchang, China
3Jiangxi Province Children's Hospital, Jiangxi Province Nanchang City, China

Yuekun Qi, PhD1,2*, Jianlin Qiao, PhD3,4, Zhenyu Li5* and Kailin Xu4*

1The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China, Xuzhou, China
2Xuzhou Medical University, Xuzhou, Xuzhou, China
3Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou City, Jiangsu Province, China
4Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China
5Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

Chengcheng Fu1*, Wenming Chen, MD, PhD2*, Zhen Cai, PhD, MD3*, Lingzhi Yan1*, Huijuan Wang, MD4*, Jingjing Shang1*, Yin Wu, MD, PhD4*, Shuang Yan, MD5*, Wen Gao, MD, PhD4, Xiaolan Shi6*, Xiaoyan Han7*, Fang Tang, MD5*, Gaofeng Zheng, MD7*, Yanling Wen, MD8*, Xingxing Meng, MD9*, Wei Zheng, PhD9*, Huamao Wang, PhD9* and Zonghai Li, MD, PhD9*

1Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China
2Department of Hematology, Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China
3Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
5National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
6The First Affiliated Hospital of Soochow University, Suzhou, China
7Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Hangzhou, China
8The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
9CARsgen Therapeutics Co. Ltd, Shanghai, China

Nelli Bejanyan, MD1, Hany Elmariah, MD, MS1, Kayla Reid, MS2*, Bin Yu3*, Jongphil Kim, PhD4*, Cheryl Cox5*, Melissa Lowden1*, Rawan Faramand, MD1, Christopher Cubitt, PhD3*, Hien Liu, MD6, Justin Boucher, PhD7*, Jose Alejandro Guevara, PhD7*, David A Sallman, MD8, Jeffrey Lancet, MD9, Joseph A. Pidala, MD1, Kumar Karyampudi, PhD5*, Frederick L. Locke, MD1, Claudio Anasetti, MD1* and Marco Davila, MD, PhD10

1Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
2H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Immune Monitoring Core, Moffitt Cancer Center, Tampa, FL
4Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
5Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL
6Moffitt Cancer Center, Tampa, FL
7Immuno-Oncology Program, Moffitt Cancer Center, Tampa, FL
8H. Lee Moffitt Cancer Center, Tampa, FL
9Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
10Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Nitin Jain, MD1, Patrice Chevallier, MD2, Hongtao Liu, MD, PhD3, Gary J. Schiller, MD4, Jean-Baptiste Méar, MD5*, Daniel J. DeAngelo6, Kevin J Curran, MD7, Stephan Grupp, MD, PhD8, Andre Baruchel, MD9*, Marie Balsat, MD10*, Alexandra LaCroce11*, Caroline Roudet, PharmD11*, Ana B. Korngold, PhD11*, Kathryn J. Newhall, PhD11*, Eric Laille, MS11*, Daniel J. Lee, MD11, Mark G. Frattini, MD, PhD11, Richard A. Larson, MD12 and Nicolas Boissel, MD, PhD13*

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Service d'hématologie, CHU de Nantes, Nantes, France
3University of Wisconsin-Madison, Madison, WI
4Hematological Malignancy/ Stem Cell Transplant Program, David Geffen School of Medicine, UCLA, Los Angeles, CA
5University Hospital of Rennes, Clinical hematology, Rennes, France
6Dana-Farber Cancer Institute, Boston, MA
7Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
8Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
9Hôpital Universitaire Robert Debré (APHP and Université Paris Cité), Paris, France
10Clinical Hematology Department, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France, Lyon, France
11Cellectis, Inc., New York, NY
12Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL
13Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, APHP, Paris, France, Paris Cedex 10, Paris, France

Ryan Stadel, PhD1*, Nethrie Idippily, PhD1*, Maria Florencia Giraudo1*, Paolo Caimi, MD2*, Koen Van Besien, MD, PhD3, James Martin, MD4*, John Wu, PhD5*, Changchun Deng, MD, PhD6 and David Wald, MD PhD1,4,7*

1Kure.ai, Cleveland, OH
2Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY
4University Hospitals Cleveland Medical Center, Cleveland, OH
5Promab, Richmond, CA
6University Hospitals Seidman Cancer Center, Cleveland, OH
7Case Western Reserve University, Cleveland, OH

Francesco Mazziotta, MD, PhD1*, Lauren E Martin1*, Miranda Lahman, PhD1*, Daniel N. Egan, MD2, Sinéad Kinsella, MSc, PhD3*, Kelly Paulson, MD, PhD4*, Yapeng Su1*, Valentin Voillet1*, Livius Penter, MD5, Catherine J Wu, MD5, Philip Greenberg, MD1* and Aude G Chapuis, MD1

1Fred Hutchinson Cancer Center, Seattle, WA
2Swedish Center for Blood Disorders and Stem Cell Transplants, Seattle, WA
3Fred Hutchinson Cancer Research Center, Seattle, WA
4Swedish Cancer Institute Medical Oncology, Seattle
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Francesca Farina1*, Bernhard Gentner, MD2*, Gaetano Finocchiaro, MD3*, Marica Eoli, MD4*, Alessia Capotondo5*, Elena Anghileri, MD4*, Matteo Barcella, PhD2*, Valentina Brambilla6*, Matteo Giovanni Carrabba7*, Valeria Cuccarini, MD8*, Quintino Giorgio D'Alessandris, MD9*, Francesco Di Meco, MD10*, Valeria Ferla, MD11*, Paolo Ferroli, MD10*, Filippo Gagliardi, MD12*, Federico Giuseppe Legnani, MD10*, Stefania Mazzoleni, PhD6*, Alessandro Olivi, MD9*, Roberto Pallini, MD9*, Massimo Saini, MD10*, Karen Mullen, MD6*, Luigi Naldini, MD, PhD2, Carlo Russo, MD13* and Fabio Ciceri14*

1IRCCS Ospedale San Raffaele, Milano, Italy
2San Raffaele Telethon Institute For Gene Therapy (SR-Tiget), IRCCS San Raffaele, Milan, Italy
3Neuro-Oncology Unit, San Raffaele Hospital, Milan, Italy
4Neuro-Oncology Unit, Istituto Neurologico Carlo Besta, Milan, Italy
5San Raffaele Telethon Institute For Gene Therapy (SR-Tiget), IRCCS San Raffaele, Milano, Italy, Italy
6Genenta Science, Milan, Italy
7Unit of Hematology and Bone Marrow Transplantation, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
8Neuroradiology Unit, Istituto Neurologico Carlo Besta, Milan, Italy
9Neurosurgery Unit, Policlinico Gemelli, Rome, Italy
10Neurosurgery Unit, Istituto Neurologico Carlo Besta, Milan, Italy
11Hematology and Bone Marrow Transplant Unit, San Raffaele Hospital, Milan, Italy
12Neurosurgery Unit, San Raffaele Hospital, Milan, Italy
13Genenta Science, New York, NY
14University Vita-Salute, IRCCS Ospedale San Raffaele, Haematology and BMT, Milan, Italy

Zongcheng Li1*, Lei Zhao2*, Yuanyuan Zhang, MD, PhD2*, Li Zhu3*, Wei Mu4*, Tong Ge3*, Jin Jin3*, Jiaqi Tan3*, Jiali Cheng3*, Jue Wang, MD4*, Na Wang3*, Xiaoxi Zhou, MD4*, Liting Chen4*, Zhilin Chang5*, Chen Liu6*, Bian Zhilei, MD7*, Bing Liu1*, Lilin Ye8*, Yu Lan9*, Liang Huang, MD3 and Jianfeng Zhou4*

1State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, CHN
2Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, CHN
4Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5Academy of Military Sciences, Beijing, CHN
6State Key Laboratory of Proteomics, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, CHN
7Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
8Institute of Immunology, Third Military Medical University, Beijing, China
9Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, Guangdong, CHN

Eyal Lebel1,2*, Nathalie Asherie2*, Shlomit Kfir-Erenfeld2,3*, Batia Avni, MD3,4*, Sigal Grisariu, MD2,4*, Shlomo Elias2,3, Miri Assayag2,3*, Tatyana Dubnikov2,3*, Nomi Zalcman3,5*, Marjorie Pick3*, Eran Zimran, MD2,3*, Yael C. Cohen6,7*, Irit Avivi Mazza, MD8*, Cyrille Cohen9*, Moshe E Gatt, MD3,10 and Polina Stepensky2,3*

1Faculty of Medicine, the Hebrew University, Jerusalem, Jerusalem, Israel
2Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Jerusalem, Israel
3Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
4Bone Marrow Transplantation & Cancer Immunotherapy Department, Hadassah-Hebrew University Medical Center and Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel
5Bone marrow transplant and cellular therapy department, Hadassah Medical Center, Jerusalem, Israel
6Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
7Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
8Hematology Division, Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
9Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life Sciences,, Bar-Ilan University, Ramat Gan, Israel
10Department of Hematology, Hadassah Medical Center, Jerusalem, Israel

Joseph P McGuirk, DO1, Sunil Abhyankar, MD1, Trishna Goswami, MD, MBA2, Halie Juarez, RN3*, Mariska ter Haak4*, Tyce Bruns3*, Samantha Youngblood4* and Lawrence S. Lamb, PhD5

1University of Kansas Medical Center, Westwood, KS
2IN8bio, Mendham, NJ
3KUMC, Kansas City, MO
4IN8bio, New York, NY
5IN8bio, Birmingham, AL

Chunrui Li1, Di Wang2*, Qiuxia Yu3*, Zhe Li2*, Wen Wang4*, Guang Hu4*, Wei Mu1*, Chunhui Li2*, Ning An5*, Xiaolu Long2* and Yuhan Bao5*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China, Wuhan, China
3Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wu Han, AL, China
4Nanjing IASO Biotherapeutics Ltd, Nanjing, China
5Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wu Han, China

Alison Moskowitz, MD1, Andreas Harstrick2*, Michael Emig, MD2*, Andre Overesch2*, Sheena Pinto2*, Paulien Ravenstijn2*, Thomas Schlüter2*, Jennifer Rubel3*, Hans Rebscher2*, Thorsten Graefe4*, John Lim4*, Heather Raymon4* and Karenza Alexis3*

1Memorial Sloan Kettering Cancer Center, New York, NY
2Affimed GmbH, Heidelberg, Germany
3Affimed Inc., New York
4Artiva Biotherapeutics Inc., San Diego

Paolo Strati, MD1, Tatyana Feldman, MD2, Christiane Querfeld, MD, PhD3, Salvia Jain, MD4, Nathanael McCurley, PhD5*, Rita Bàrcia, PhD5*, Koby Kidder, PhD5* and Jelle Kylstra, MD, MBA5*

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2John Theurer Cancer Center, Hackensack, NJ
3City of Hope, Duarte, CA
4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA
5SIRPant Immunotherapeutics, Hummelstown, PA

Michael L. Wang, MD1, Matthew J. Frigault, MD, MS2, Salim Yazji, MD3, Yisrael Katz, MD3*, James Robinson, MS3*, James B. Breitmeyer, MD, PhD4, Matthew G. Mei, MD5 and Caron A Jacobson, MD, MMSc6

1The University of Texas MD Anderson Cancer Center, Houston, TX
2Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA
3Oncternal Therapeutics, San Diego, CA
4Oncternal Therapeutics, Inc, San Diego, CA
5City of Hope National Medical Center, Duarte, CA
6Dana-Farber Cancer Institute, Boston, MA

Sunmin Park, MD/PhD1, Christopher Hannigan, B.S.2*, Joseph M Tuscano, MD3, John Timmerman, MD4 and Caspian H. Oliai, MD5

1Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA
2University of California, Los Angeles, Los Angeles, CA
3University of California, Davis Medical Center, Sacramento, CA
4UCLA Medical Center, Los Angeles, CA
5Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA

Niels W.C.J. van de Donk1, Sébastien Anguille2*, Jo Caers3*, Marte C. Liefaard4*, Christian Jacques4 and Anna D.D. van Muyden4*

1Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
2Antwerp University Hospital, Antwerp, Belgium
3Centre Hospitalier Universitaire de Liège, Liège, Belgium
4CellPoint BV, a Galapagos company, Oegstgeest, Netherlands

Emily C Liang, MD1,2, Erik L Kimble, MD1,2, Aya Albittar, MD1,2*, Jennifer J. Huang, MD, PhD1,2, Andrew J Portuguese, MD1,2, Aiko Torkelson, BS2*, Delaney Kirchmeier, BS2*, Abigail Chutnik, BS2*, Barbara Pender, MSc2*, Sylvain Simon, PhD3*, Tony Chour, BS1,2*, Evan W. Newell, PhD2*, Rahul Banerjee, MD1,2, David G Maloney, MD, PhD2,4, Alexander Spicer, MSc5*, Juho Jalkanen, MD, PhD5*, Alexandre V Hirayama, MD2,4* and Jordan Gauthier, MD, MSc4,6

1University of Washington, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
4Division of Medical Oncology, University of Washington, Seattle, WA
5Faron Pharmaceuticals, Turku, Finland
6Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Raynier Devillier, MD, PhD1*, Regis Peffault De Latour2*, Patrice Chevallier, MD3, Anne Huynh, MD4*, Patrizia Chiusolo5*, Aurelie Bauquet6*, Laura Simons, MD, PhD7*, Pierre Heimendinger8*, Olivier Negre, PhD9*, Shabi Soheili, PhD10*, Juliette Paillet8*, Isabelle Andre, PhD11*, Sebastien Oster8*, Marina Cavazzana, MD, PhD12,13, Frédéric François Lehmann8* and Fabio Ciceri14*

1Hematology and Transplantation, Institut Paoli-Calmettes, Aix Marseille University, Marseille, France
2Hôpital Saint-Louis, Hematology Department, AP-HP, Paris, France
3CHU de Nantes - Hôtel Dieu, Nantes, France
4Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
5Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
6Smart Immune, Paris, AL, FRA
7Smart Immune, Paris, FRA
8Smart Immune, Paris, France
9Smart Immune, PARIS, MA, FRA
10Institut Imagine, Paris, FRA
11Paris Cité University, Imagine Institute, INSERM UMR 1163, Paris, France
12Pediatric Immunology, Imagine Institute, Paris, FRA
13Department of Biotherapy, Hospital Necker, University Paris Descartes, Paris, France
14Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy

Nirali N. Shah, M.D.1, Jacques Azzi2, Brenda W Cooper, MD3, Abhinav Deol, MD4*, John DiPersio5, Divya Koura, MD6, Brian McClune, DO7, Lori S. Muffly, MD8, Muhammad Umair Mushtaq, MD9, Rupa Narayan, MD10, Hyung Chan Suh, MD, PhD11, Gregory Yanik, MD12*, Sritama Nath, PhD13*, Jennifer Whangbo, MD, PhD13 and Guenther Koehne, MD, PhD14

1Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD
2Division of Hematology & Medical Oncology, Cellular Therapy and Bone Marrow Transplant, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
3University Hospitals Seidman Cancer Center, Cleveland, OH
4Karmanos Cancer Institute/ Department of Oncology, Wayne State University, Detroit, MI
5Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University, Saint Louis, MO
6UCSD Moores Cancer Center, La Jolla, CA
7Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
8Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA
9Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
10Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
11Hackensack University Medical Center, Hackensack, NJ
12Rogel Cancer Center, University of Michigan, Ann Arbor, MI
13Vor Biopharma, Cambridge, MA
14Baptist Health South Florida, Miami Cancer Institute, Miami, FL

Abhishek Maiti, MD1, Muharrem Muftuoglu, MD2, James J. Ignatz-Hoover, MD, PhD3*, Courtney D. DiNardo, MD, MSc4, Farhad Ravandi, MD, MBBS4, Michael Andreeff, MD PhD4, Lianchun Xiao5*, Xuelin Huang, PhD6*, Keyur P. Patel, MBBS, PhD7, Jason B Litten, MD8*, Eliot Bourk8*, Stephanie Astrow8*, Hagop M. Kantarjian, MD4, Ben K. Tomlinson, MD9, Naval Daver, MD4 and David Wald10*

1Department of Leukemia, MD Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology and Therapy, Department of Leukemia, Houston, TX
3Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston
6Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
8Chimeric Therapeutics, Carlton, Australia
9University Hospitals Seidman Cancer Center, Cleveland, OH
10Case Western Reserve University, Cleveland, OH

*signifies non-member of ASH